Login / Signup

Low-dose PTCy plus low-dose ATG as GVHD prophylaxis after UD-PBSCT for hematologic malignancies: a prospective, multicenter, randomized controlled trial.

Yingling ZuRuirui GuiZhen LiJuan WangYanli ZhangFengkuan YuHuifang ZhaoXinrong ZhanZhongliang WangPengtao XingXianjing WangHuili WangYongping SongJian Zhou
Published in: Blood cancer journal (2023)
Keyphrases
  • low dose
  • randomized controlled trial
  • high dose
  • study protocol
  • cross sectional
  • acute lymphoblastic leukemia